Berberine reduces circulating inflammatory mediators in patients with severe COVID-19 | British Journal of Surgery | Oxford Academic
Berberine is 18 times more potent than Metformin in killing SARS-Cov-2, 1.5 times more potent than paxlovid. Berberine powerfully mitigates inflammatory cascade responses to SARS-Cov-2